A Multicenter Randomized Controlled Study of Interventional Treatment for Operable Stage Ⅱ-Ⅲ Non-small Cell Lung Cancer With Potential Recurrence as Minimal Residual Disease(MRD) Positive
Clinical trial NCT06524518 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06524518
- Sponsor
- Xuanwu Hospital, Beijing
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-01
- Primary completion
- 2026-07-01
- Enrollment
- 213
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.